INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2017

Coffee consumption was linked to a lower risk of multiple cancers, cardiovascular disease, mortality, Parkinson's disease, and type-2 diabetes.

An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.

Shows an association, not proof of cause and effect.

Study type
Umbrella review of meta-analyses of observational studies and RCTs
Who was studied
Participants across 112 observational meta-analyses, 20 caffeine observational meta-analyses, and 9 RCT meta-analyses
What was measured
Various health outcomes including cancers, cardiovascular disease, mortality, Parkinson's disease, type-2 diabetes, serum lipids, and blood pressure

THE PAPER

Coffee, Caffeine, and Health Outcomes: An Umbrella Review.

Grosso G, Godos J, Galvano F, Giovannucci EL. Annu Rev Nutr, 2017.

PubMed 28826374 ↗DOI 10.1146/annurev-nutr-071816-064941 ↗

Heart & arteriesDiabetes & blood sugarCancerBlood pressureBrain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.